More on IPXL

- Summary
- Chart
- Profile
- Historical


- Earnings (+21.2% Growth)
- Ratings (3.9 Score)
- Holders
- FDA Archive


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (2/24/16 *Est.)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

IPXL Balance Sheet

Click line-items for a historical chart and %
Current assets:
Cash and cash equivalents 318.4M
Short-term investments 0
Accounts receivable, net 228.5M
Inventory, net 130.27M
Deferred product manufacturing costs
Deferred income taxes 83.5M
Prepaid expenses and other current assets 37.12M
Total current assets 797.8M
Property, plant and equipment, net 206.13M
Deferred product manufacturing costs
Deferred income taxes, net 131K
Other assets 66.3M
Goodwill 210.17M
Total assets 2B
Current liabilities:
Accounts payable 37.27M
Accrued expenses 159.89M
Accrued income taxes payable
Accrued profit sharing and royalty expenses 37.42M
Deferred revenue 907K
Total current liabilities 235.49M
Deferred revenue 2.72M
Other liabilities 35.02M
Total liabilities 967.21M
Commitments and contingencies (Note 8) 0
Stockholders' equity:
Preferred Stock, $ 0.01 par value, 2,000,000 shares authorized, 0 shares outstanding at June 30, 2011 and December 31, 2010 0
Common stock, $ 0.01 par value, 90,000,000 shares authorized and 65,872,062 and 64,721,041 shares issued at June 30, 2011 and December 31, 2010, respectively 731K
Additional paid-in capital 482.43M
Treasury stock-243,729 shares -2.16M
Accumulated other comprehensive income -11.13M
Retained earnings 558.8M
Stockholders' Equity Attributable to Parent, Total
Noncontrolling interest
Total stockholders' equity 1.03B
Total liabilities and stockholders' equity 2B